Haemonetics Corp Files 8-K on Shareholder Votes
Ticker: HAE · Form: 8-K · Filed: Jul 25, 2025 · CIK: 313143
| Field | Detail |
|---|---|
| Company | Haemonetics Corp (HAE) |
| Form Type | 8-K |
| Filed Date | Jul 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance, sec-filing
Related Tickers: HAE
TL;DR
HAE filed an 8-K for shareholder votes on 7/24.
AI Summary
Haemonetics Corporation filed an 8-K on July 25, 2025, reporting on matters submitted to a vote of security holders as of July 24, 2025. The filing details events related to shareholder votes, though specific outcomes or proposals are not detailed in this excerpt. The company is incorporated in Massachusetts and headquartered in Boston.
Why It Matters
This filing indicates that Haemonetics Corporation held or is reporting on a shareholder vote, which can signal important corporate decisions or changes affecting investors.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of shareholder voting matters and does not contain information about significant financial changes, legal issues, or executive departures.
Key Numbers
- 001-14041 — SEC File Number (Identifies the company's filing history with the SEC.)
- 04-2882273 — I.R.S. Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Haemonetics Corporation (company) — Registrant
- Massachusetts (location) — State of incorporation
- Boston (location) — Principal executive offices city
- 02110 (location) — Principal executive offices zip code
- 781-848-7100 (phone_number) — Registrant's telephone number
FAQ
What specific matters were submitted to a vote of Haemonetics Corporation's security holders on July 24, 2025?
The provided excerpt does not specify the exact matters submitted to a vote; it only indicates that such matters were reported on in the 8-K filing.
When was this Form 8-K filed with the SEC?
The Form 8-K was filed as of date July 25, 2025.
What is Haemonetics Corporation's principal executive office address?
The principal executive offices are located at 125 Summer Street, Boston, MA 02110.
What is the SIC code for Haemonetics Corporation?
The Standard Industrial Classification (SIC) code is 3841 for Surgical & Medical Instruments & Apparatus.
What is the fiscal year end for Haemonetics Corporation?
The fiscal year end for Haemonetics Corporation is March 29.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 25, 2025 regarding HAEMONETICS CORP (HAE).